{"id":12602,"date":"2023-01-04T16:10:01","date_gmt":"2023-01-04T16:10:01","guid":{"rendered":"https:\/\/www.lymphoma.ca\/?p=12602"},"modified":"2023-02-03T14:36:54","modified_gmt":"2023-02-03T14:36:54","slug":"nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc","status":"publish","type":"post","link":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/","title":{"rendered":"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC)"},"content":{"rendered":"[vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column_text]<strong>Date et heure : Le 31 janvier 2023, \u00e0 16 h 30 HNE<\/strong><\/p>\n<p>Chaque ann\u00e9e, les scientifiques et les m\u00e9decins approfondissent leurs connaissances sur la fa\u00e7on de traiter les diff\u00e9rents types de lymphome. Ces derniers temps, les options th\u00e9rapeutiques pour les patients atteints d\u2019un lymphome ou d\u2019une LLC sont pass\u00e9es de la chimioth\u00e9rapie aux th\u00e9rapies cibl\u00e9es qui entra\u00eenent moins d\u2019effets secondaires et dont la puissance est accrue. Ce webinaire couvrira les avanc\u00e9es r\u00e9centes en mati\u00e8re d\u2019options th\u00e9rapeutiques offertes aux Canadiens aux prises avec diff\u00e9rents sous-types de lymphomes.<\/p>\n<p><strong>Conf\u00e9renci\u00e8re : Dre St\u00e9phanie Corriveau<\/strong><\/p>\n<p>La Dre Corriveau a re\u00e7u une formation de m\u00e9decin de famille au Centre hospitalier universitaire de Sherbrooke. Elle est sp\u00e9cialis\u00e9e en h\u00e9matologie.[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][nectar_btn size=\u00a0\u00bblarge\u00a0\u00bb open_new_tab=\u00a0\u00bbtrue\u00a0\u00bb button_style=\u00a0\u00bbregular\u00a0\u00bb button_color_2=\u00a0\u00bbAccent-Color\u00a0\u00bb icon_family=\u00a0\u00bbnone\u00a0\u00bb text=\u00a0\u00bbVoir les diapos ici\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/attendee.gotowebinar.com\/recording\/6160094587815229024&Prime;][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb&#8230;<\/p>\n","protected":false},"author":35,"featured_media":12613,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12,73],"tags":[135,173,190,167],"class_list":{"0":"post-12602","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-evenements","8":"category-special-topic-fr","9":"tag-covid-19-fr","10":"tag-covid-19-fr-2","11":"tag-webinaire","12":"tag-webinar-fr"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC) -<\/title>\n<meta name=\"description\" content=\"Chaque ann\u00e9e, les scientifiques et les m\u00e9decins approfondissent leurs connaissances sur la fa\u00e7on de traiter les diff\u00e9rents types de lymphome. Ces derniers temps, les options th\u00e9rapeutiques pour les patients atteints d\u2019un lymphome ou d\u2019une LLC sont pass\u00e9es de la chimioth\u00e9rapie aux th\u00e9rapies cibl\u00e9es qui entra\u00eenent moins d\u2019effets secondaires et dont la puissance est accrue. Ce webinaire couvrira les avanc\u00e9es r\u00e9centes en mati\u00e8re d\u2019options th\u00e9rapeutiques offertes aux Canadiens aux prises avec diff\u00e9rents sous-types de lymphomes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC) -\" \/>\n<meta property=\"og:description\" content=\"Chaque ann\u00e9e, les scientifiques et les m\u00e9decins approfondissent leurs connaissances sur la fa\u00e7on de traiter les diff\u00e9rents types de lymphome. Ces derniers temps, les options th\u00e9rapeutiques pour les patients atteints d\u2019un lymphome ou d\u2019une LLC sont pass\u00e9es de la chimioth\u00e9rapie aux th\u00e9rapies cibl\u00e9es qui entra\u00eenent moins d\u2019effets secondaires et dont la puissance est accrue. Ce webinaire couvrira les avanc\u00e9es r\u00e9centes en mati\u00e8re d\u2019options th\u00e9rapeutiques offertes aux Canadiens aux prises avec diff\u00e9rents sous-types de lymphomes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LymphomaCanada\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-04T16:10:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-03T14:36:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adam\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:site\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"adam\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/\"},\"author\":{\"name\":\"adam\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/92bc5615d7f9c6cb8db1790b0b82fe2e\"},\"headline\":\"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC)\",\"datePublished\":\"2023-01-04T16:10:01+00:00\",\"dateModified\":\"2023-02-03T14:36:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/\"},\"wordCount\":445,\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg\",\"keywords\":[\"covid-19\",\"covid-19\",\"webinaire\",\"webinar\"],\"articleSection\":[\"\u00c9v\u00e9nements\",\"special topic fr\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/\",\"name\":\"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC) -\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg\",\"datePublished\":\"2023-01-04T16:10:01+00:00\",\"dateModified\":\"2023-02-03T14:36:54+00:00\",\"description\":\"Chaque ann\u00e9e, les scientifiques et les m\u00e9decins approfondissent leurs connaissances sur la fa\u00e7on de traiter les diff\u00e9rents types de lymphome. Ces derniers temps, les options th\u00e9rapeutiques pour les patients atteints d\u2019un lymphome ou d\u2019une LLC sont pass\u00e9es de la chimioth\u00e9rapie aux th\u00e9rapies cibl\u00e9es qui entra\u00eenent moins d\u2019effets secondaires et dont la puissance est accrue. Ce webinaire couvrira les avanc\u00e9es r\u00e9centes en mati\u00e8re d\u2019options th\u00e9rapeutiques offertes aux Canadiens aux prises avec diff\u00e9rents sous-types de lymphomes.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#primaryimage\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"woman studying at home.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lymphoma.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"name\":\"Lymphoma Canada\",\"description\":\"Information. Help. Hope.\",\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\",\"name\":\"Lymphoma Canada\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"width\":343,\"height\":343,\"caption\":\"Lymphoma Canada\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LymphomaCanada\",\"https:\/\/x.com\/lymphomacanada\",\"https:\/\/www.linkedin.com\/company\/lymphoma-canada\/\",\"http:\/\/instagram.com\/lymphomacanada\",\"http:\/\/www.youtube.com\/user\/LymphomaTV\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/92bc5615d7f9c6cb8db1790b0b82fe2e\",\"name\":\"adam\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0354078686ab104912fd42b421733dd1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0354078686ab104912fd42b421733dd1?s=96&d=mm&r=g\",\"caption\":\"adam\"},\"url\":\"https:\/\/www.lymphoma.ca\/fr\/author\/adam\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC) -","description":"Chaque ann\u00e9e, les scientifiques et les m\u00e9decins approfondissent leurs connaissances sur la fa\u00e7on de traiter les diff\u00e9rents types de lymphome. Ces derniers temps, les options th\u00e9rapeutiques pour les patients atteints d\u2019un lymphome ou d\u2019une LLC sont pass\u00e9es de la chimioth\u00e9rapie aux th\u00e9rapies cibl\u00e9es qui entra\u00eenent moins d\u2019effets secondaires et dont la puissance est accrue. Ce webinaire couvrira les avanc\u00e9es r\u00e9centes en mati\u00e8re d\u2019options th\u00e9rapeutiques offertes aux Canadiens aux prises avec diff\u00e9rents sous-types de lymphomes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/","og_locale":"fr_FR","og_type":"article","og_title":"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC) -","og_description":"Chaque ann\u00e9e, les scientifiques et les m\u00e9decins approfondissent leurs connaissances sur la fa\u00e7on de traiter les diff\u00e9rents types de lymphome. Ces derniers temps, les options th\u00e9rapeutiques pour les patients atteints d\u2019un lymphome ou d\u2019une LLC sont pass\u00e9es de la chimioth\u00e9rapie aux th\u00e9rapies cibl\u00e9es qui entra\u00eenent moins d\u2019effets secondaires et dont la puissance est accrue. Ce webinaire couvrira les avanc\u00e9es r\u00e9centes en mati\u00e8re d\u2019options th\u00e9rapeutiques offertes aux Canadiens aux prises avec diff\u00e9rents sous-types de lymphomes.","og_url":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/","og_site_name":"Lymphoma Canada","article_publisher":"https:\/\/www.facebook.com\/LymphomaCanada","article_published_time":"2023-01-04T16:10:01+00:00","article_modified_time":"2023-02-03T14:36:54+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg","type":"image\/jpeg"}],"author":"adam","twitter_card":"summary_large_image","twitter_creator":"@lymphomacanada","twitter_site":"@lymphomacanada","twitter_misc":{"\u00c9crit par":"adam","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#article","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/"},"author":{"name":"adam","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/92bc5615d7f9c6cb8db1790b0b82fe2e"},"headline":"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC)","datePublished":"2023-01-04T16:10:01+00:00","dateModified":"2023-02-03T14:36:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/"},"wordCount":445,"publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg","keywords":["covid-19","covid-19","webinaire","webinar"],"articleSection":["\u00c9v\u00e9nements","special topic fr"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/","url":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/","name":"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC) -","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#primaryimage"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg","datePublished":"2023-01-04T16:10:01+00:00","dateModified":"2023-02-03T14:36:54+00:00","description":"Chaque ann\u00e9e, les scientifiques et les m\u00e9decins approfondissent leurs connaissances sur la fa\u00e7on de traiter les diff\u00e9rents types de lymphome. Ces derniers temps, les options th\u00e9rapeutiques pour les patients atteints d\u2019un lymphome ou d\u2019une LLC sont pass\u00e9es de la chimioth\u00e9rapie aux th\u00e9rapies cibl\u00e9es qui entra\u00eenent moins d\u2019effets secondaires et dont la puissance est accrue. Ce webinaire couvrira les avanc\u00e9es r\u00e9centes en mati\u00e8re d\u2019options th\u00e9rapeutiques offertes aux Canadiens aux prises avec diff\u00e9rents sous-types de lymphomes.","breadcrumb":{"@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#primaryimage","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/01\/iStock-1370511233-scaled.jpg","width":2560,"height":1707,"caption":"woman studying at home."},{"@type":"BreadcrumbList","@id":"https:\/\/www.lymphoma.ca\/fr\/nouvelles-therapies-innovantes-pour-les-patients-atteints-dun-lymphome-ou-dune-leucemie-lymphoide-chronique-llc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lymphoma.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Webinaire : Nouvelles th\u00e9rapies innovantes pour les patients atteints d\u2019un lymphome ou d\u2019une leuc\u00e9mie lympho\u00efde chronique (LLC)"}]},{"@type":"WebSite","@id":"https:\/\/www.lymphoma.ca\/fr\/#website","url":"https:\/\/www.lymphoma.ca\/fr\/","name":"Lymphoma Canada","description":"Information. Help. Hope.","publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lymphoma.ca\/fr\/#organization","name":"Lymphoma Canada","url":"https:\/\/www.lymphoma.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","width":343,"height":343,"caption":"Lymphoma Canada"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LymphomaCanada","https:\/\/x.com\/lymphomacanada","https:\/\/www.linkedin.com\/company\/lymphoma-canada\/","http:\/\/instagram.com\/lymphomacanada","http:\/\/www.youtube.com\/user\/LymphomaTV"]},{"@type":"Person","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/92bc5615d7f9c6cb8db1790b0b82fe2e","name":"adam","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0354078686ab104912fd42b421733dd1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0354078686ab104912fd42b421733dd1?s=96&d=mm&r=g","caption":"adam"},"url":"https:\/\/www.lymphoma.ca\/fr\/author\/adam\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/12602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/comments?post=12602"}],"version-history":[{"count":5,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/12602\/revisions"}],"predecessor-version":[{"id":12793,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/12602\/revisions\/12793"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media\/12613"}],"wp:attachment":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media?parent=12602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/categories?post=12602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/tags?post=12602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}